http://dbpedia.org/ontology/abstract
|
ザイマージェン(英: Zymergen Inc. )は、アメリカ合衆国カリフォルニア州エメリービルに本社を置くバイオテクノロジー企業。ゲノミクスと機械学習を応用した遺伝子組換え微生物の設計、製造および研究を手がけている。
, Zymergen is an American biotechnology comp … Zymergen is an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. Shortly after going public in 2021, it was reported that the company was facing difficulties in manufacturing products and struggling to make revenue. In July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million.reed to acquire Zymergen for $300 million.
|
http://dbpedia.org/ontology/foundingYear
|
2013
|
http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Steven_Chu +
|
http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/Emeryville%2C_California +
|
http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/Ginkgo_Bioworks +
|
http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Subsidiary +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.zymergen.com/ +
|
http://dbpedia.org/ontology/wikiPageID
|
69616363
|
http://dbpedia.org/ontology/wikiPageLength
|
13044
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1122462443
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Fortune_500 +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Theranos +
, http://dbpedia.org/resource/SoftBank +
, http://dbpedia.org/resource/Category:2013_establishments_in_California +
, http://dbpedia.org/resource/SoftBank_Vision_Fund +
, http://dbpedia.org/resource/Steven_Chu +
, http://dbpedia.org/resource/Category:Companies_based_in_California +
, http://dbpedia.org/resource/Goldman_Sachs +
, http://dbpedia.org/resource/Cathie_Wood +
, http://dbpedia.org/resource/U.S._Securities_and_Exchange_Commission +
, http://dbpedia.org/resource/DARPA +
, http://dbpedia.org/resource/Illumina%2C_Inc. +
, http://dbpedia.org/resource/Ginkgo_Bioworks +
, http://dbpedia.org/resource/Market_capitalization +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Amyris_%28company%29 +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Precigen +
, http://dbpedia.org/resource/Machine_learning +
, http://dbpedia.org/resource/IPO +
, http://dbpedia.org/resource/Category:2022_mergers_and_acquisitions +
, http://dbpedia.org/resource/JPMorgan_Chase +
, http://dbpedia.org/resource/Genomics +
, http://dbpedia.org/resource/Genetically_modified_organisms +
, http://dbpedia.org/resource/Emeryville%2C_California +
|
http://dbpedia.org/property/hqLocationCity
|
http://dbpedia.org/resource/Emeryville%2C_California +
|
http://dbpedia.org/property/hqLocationCountry
|
U.S.
|
http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Steven_Chu +
, Jay Flatley
|
http://dbpedia.org/property/name
|
Zymergen Inc.
|
http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/Ginkgo_Bioworks +
|
http://dbpedia.org/property/tradedAs
|
NASDAQ:ZY
|
http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Subsidiary +
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Official +
, http://dbpedia.org/resource/Template:Ubl +
, http://dbpedia.org/resource/Template:URL +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:2013_establishments_in_California +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:2022_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:Companies_based_in_California +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Zymergen?oldid=1122462443&ns=0 +
|
http://xmlns.com/foaf/0.1/homepage
|
https://www.zymergen.com/ +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Zymergen +
|
http://xmlns.com/foaf/0.1/name
|
Zymergen Inc.
|
owl:sameAs |
http://www.wikidata.org/entity/Q65239425 +
, http://dbpedia.org/resource/Zymergen +
, http://ja.dbpedia.org/resource/%E3%82%B6%E3%82%A4%E3%83%9E%E3%83%BC%E3%82%B8%E3%82%A7%E3%83%B3 +
, https://global.dbpedia.org/id/A3PmG +
|
rdf:type |
http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q24229398 +
|
rdfs:comment |
ザイマージェン(英: Zymergen Inc. )は、アメリカ合衆国カリフォルニア州エメリービルに本社を置くバイオテクノロジー企業。ゲノミクスと機械学習を応用した遺伝子組換え微生物の設計、製造および研究を手がけている。
, Zymergen is an American biotechnology comp … Zymergen is an American biotechnology company based in Emeryville, California. The company applies genomics and machine learning to research and design chemical producing genetically modified organisms. Shortly after going public in 2021, it was reported that the company was facing difficulties in manufacturing products and struggling to make revenue. In July 2022, Ginkgo Bioworks agreed to acquire Zymergen for $300 million.reed to acquire Zymergen for $300 million.
|
rdfs:label |
Zymergen
, ザイマージェン
|